TEAS Plus New Application

TI FIS

QPharma, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97544430
Filing Date: 08/11/2022

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK Ti FIS
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT Ti FIS
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK QPharma, Inc.
DBA/AKA/TA/FORMERLY AKA QPharma
*MAILING ADDRESS 22 South Street
*CITY Morristown
*STATE
(Required for U.S. applicants)
New Jersey
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
07960
PHONE 973-656-0011
*EMAIL ADDRESS XXXX
WEBSITE ADDRESS http://qpharmacorp.com
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION New Jersey
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 042 
*IDENTIFICATION Consulting services in the field of software as a service (SAAS)
*FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 10/01/2017
       FIRST USE IN COMMERCE DATE At least as early as 10/12/2017
       SPECIMEN
       FILE NAME(S)
\\TICRS\EXPORT18\IMAGEOUT 18\975\444\97544430\xml1 \ FTK0003.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\975\444\97544430\xml1 \ FTK0004.JPG
       SPECIMEN DESCRIPTION The Ti FIS application allows the field agents to capture inventory data electronically and supply data directly to QPharma's Ti Sample(TM) application (or third-party sample accountability platforms) for reconciliation and reporting purposes.
        WEBPAGE URL None Provided
        WEBPAGE DATE OF ACCESS None Provided
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
CORRESPONDENCE INFORMATION
NAME QPharma, Inc.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ycelso.venturaiii@qpharmacorp.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) dawn.gabriel@qpharmacorp.com; reno.amadori@qpharmacorp.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /YAV/
* SIGNATORY'S NAME Ycelso Ventura III
* SIGNATORY'S POSITION Specialist Quality and Compliance
SIGNATORY'S PHONE NUMBER 973-656-0011
* DATE SIGNED 08/11/2022
SIGNATURE METHOD Signed directly within the form



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97544430
Filing Date: 08/11/2022

To the Commissioner for Trademarks:

MARK: Ti FIS (Standard Characters, see mark)
The literal element of the mark consists of Ti FIS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, QPharma, Inc., AKA QPharma, a corporation of New Jersey, having an address of
      22 South Street
      Morristown, New Jersey 07960
      United States
      973-656-0011(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 042:  Consulting services in the field of software as a service (SAAS)

Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.

In International Class 042, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 10/01/2017, and first used in commerce at least as early as 10/12/2017, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) The Ti FIS application allows the field agents to capture inventory data electronically and supply data directly to QPharma's Ti Sample(TM) application (or third-party sample accountability platforms) for reconciliation and reporting purposes..
Specimen File1
Specimen File2

Webpage URL: None Provided
Webpage Date of Access: None Provided


For informational purposes only, applicant's website address is: http://qpharmacorp.com
The applicant's current Correspondence Information:
      QPharma, Inc.
       PRIMARY EMAIL FOR CORRESPONDENCE: ycelso.venturaiii@qpharmacorp.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): dawn.gabriel@qpharmacorp.com; reno.amadori@qpharmacorp.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /YAV/   Date: 08/11/2022
Signatory's Name: Ycelso Ventura III
Signatory's Position: Specialist Quality and Compliance
Signatory's Phone Number: 973-656-0011
Signature method: Signed directly within the form
Payment Sale Number: 97544430
Payment Accounting Date: 08/11/2022

Serial Number: 97544430
Internet Transmission Date: Thu Aug 11 12:15:35 ET 2022
TEAS Stamp: USPTO/FTK-XXX.X.XXX.XXX-2022081112153522
5318-97544430-82051c83027412a46ac3a1b5d4
892aa16ec584822ccb23eb514ebaee73426434e-
CC-15330988-20220811114517975895

TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed